Pressmeddelanden

Ny testmetod kan ge säkrare dosering av hydroxiklorokin

2020-06-01 02:00 CEST
Forskare vid Uppsala universitet och Akademiska sjukhuset har tagit fram en ny metod fö...

Imfinzi plus tremelimumab demonstrated promising clinical  activity and tolerability in patients with advanced liver cancer

Imfinzi plus tremelimumab demonstrated promising clinical activity and tolerability in patients with advanced liver cancer

2020-05-29 14:56 CEST
Results from the global Phase II Study 22 trial testing AstraZeneca’s tremelimumab, an ...

Enhertu achieved a tumour response rate of 45.3% in patients with HER2-positive metastatic colorectal cancer in Phase II DESTINY-CRC01 trial

Enhertu achieved a tumour response rate of 45.3% in patients with HER2-positive metastatic colorectal cancer in Phase II DESTINY-CRC01 trial

2020-05-29 14:53 CEST
Results from the Phase II DESTINY-CRC01 trial of AstraZeneca and Daiichi Sankyo Company...

Enhertu demonstrated meaningful clinical activity in patients with HER2-mutant non-small cell lung cancer in interim analysis of Phase II  DESTINY-Lung01 trial

Enhertu demonstrated meaningful clinical activity in patients with HER2-mutant non-small cell lung cancer in interim analysis of Phase II DESTINY-Lung01 trial

2020-05-29 14:42 CEST
Results from the ongoing Phase II DESTINY-Lung01 trial showed AstraZeneca and Daiichi S...

Enhertu significantly improved tumour response rate and overall survival in HER2-positive metastatic gastric cancer in Phase II DESTINY-Gastric01 trial

Enhertu significantly improved tumour response rate and overall survival in HER2-positive metastatic gastric cancer in Phase II DESTINY-Gastric01 trial

2020-05-29 14:09 CEST
Detailed results from the positive, registrational, randomised controlled Phase II DEST...

Imfinzi showed a sustained overall survival benefit in 1st-line  extensive-stage small cell lung cancer in the Phase III CASPIAN trial

Imfinzi showed a sustained overall survival benefit in 1st-line extensive-stage small cell lung cancer in the Phase III CASPIAN trial

2020-05-29 14:03 CEST
Detailed results from an updated analysis of the Phase III CASPIAN trial showed AstraZe...

Ny vårdbyggnad vid Danderyds sjukhus planeras

Ny vårdbyggnad vid Danderyds sjukhus planeras

2020-05-29 07:30 CEST
Nu tar Danderyds sjukhus nästa steg i arbetet med att säkerställa lokaler som effektivi...

Världsberömd fransk neurokirurg blir hedersdoktor i Umeå

Världsberömd fransk neurokirurg blir hedersdoktor i Umeå

2020-05-29 07:10 CEST
Alim-Louis Benabid blir 2020 års hedersdoktor vid Medicinska fakulteten vid Umeå univer...

Tagrisso demonstrated unprecedented disease-free survival in the adjuvant treatment of Stage IB-IIIA patients with EGFR-mutated lung cancer

Tagrisso demonstrated unprecedented disease-free survival in the adjuvant treatment of Stage IB-IIIA patients with EGFR-mutated lung cancer

2020-05-28 23:03 CEST
Detailed results from the Phase III ADAURA trial showed AstraZeneca’s Tagrisso (osimert...

Vi vill bryta ensamheten hos ms-sjuka på Internationella MS-dagen genom ett livestreamat evenemang

2020-05-28 16:35 CEST
Merck och livestreamplattformenTwitch samarbetar på Internationella MS-dagen för att ök...